Jelena D. Milosevic Feenstra

Author

Also Known As

J D M Feenstra, J D Milosevic, J Milośevic, J. D. Milosevic, J. Milosevic, Jelena D M Feenstra, Jelena D Milosevic Feenstra, Jelena D. M. Feenstra, Jelena D. Milosevic, Jelena D. Milosevic Feenstra

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Austrian Academy of Sciences CeMM Research Center for Molecular Medicine Medical University of Vienna University of Pavia Istituti di Ricovero e Cura a Carattere Scientifico

About

Jelena D. Milosevic Feenstra is an author at Austrian Academy of Sciences specializing in oncology, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	254
2	Pathology	4	4	254
3	Cell Biology	3	3	177
4	Health Sciences	1	1	104
5	Cancer Cell Biology	1	1	104

Jelena D. Milosevic Feenstra

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms Thorsten Klampfl, Heinz Gisslinger, Ashot S. Harutyunyan, New England Journal of Medicine	2013	1.9K
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes Elisa Rumi, Daniela Pietra, Virginia Valeria Ferretti, Blood	2013	572
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms Jelena D. Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, Blood	2015	270
Loss of <i>Ezh2</i> synergizes with <i>JAK2</i> -V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis Takafumi Shimizu, Lucia Kubovčáková, Ronny Nienhold, The Journal of Experimental Medicine	2016	113
Chromothripsis in acute myeloid leukemia: biological features and impact on survival Maria Chiara Fontana, Giovanni Marconi, Jelena D. Milosevic Feenstra, Leukemia	2018	111
Frequent deletions of <i>JARID2</i> in leukemic transformation of chronic myeloid malignancies Ana Puda, Jelena D. Milosevic Feenstra, Tiina Berg, American Journal of Hematology Leukemic TransformationMixed-phenotype Acute LeukemiaGeneticsPathologyEpigenetics	2011	104
Clinical significance of genetic aberrations in secondary acute myeloid leukemia Jelena D. Milosevic Feenstra, Ana Puda, Luca Malcovati, American Journal of Hematology Mixed-phenotype Acute LeukemiaGeneticsGenetic EpidemiologyPathologyGenetic Aberrations	2012	77
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis Elisa Rumi, Ashot S. Harutyunyan, Daniela Pietra, Blood	2014	71
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms Fiorella Schischlik, Roland Jäger, Felix Rosebrock, Blood	2019	69
Efficacy of Ruxolitinib in Chronic Eosinophilic Leukemia Associated With a <i>PCM1-JAK2</i> Fusion Gene Elisa Rumi, Jelena D. Milosevic Feenstra, Ilaria Carola Casetti, Journal of Clinical Oncology Hematological MalignancyCancer ResearchMedicineMalignant Blood DisorderPathology	2013	56

Page 1